U.S Physical Therapy Net Income 2010-2024 | USPH

U.S Physical Therapy net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
U.S Physical Therapy Annual Net Income
(Millions of US $)
2023 $28
2022 $32
2021 $41
2020 $35
2019 $40
2018 $35
2017 $22
2016 $21
2015 $21
2014 $19
2013 $13
2012 $18
2011 $21
2010 $16
2009 $12
U.S Physical Therapy Quarterly Net Income
(Millions of US $)
2024-09-30 $7
2024-06-30 $7
2024-03-31 $8
2023-12-31 $3
2023-09-30 $9
2023-06-30 $9
2023-03-31 $7
2022-12-31 $3
2022-09-30 $10
2022-06-30 $11
2022-03-31 $9
2021-12-31 $10
2021-09-30 $10
2021-06-30 $12
2021-03-31 $8
2020-12-31 $13
2020-09-30 $11
2020-06-30 $10
2020-03-31 $1
2019-12-31 $8
2019-09-30 $9
2019-06-30 $15
2019-03-31 $8
2018-12-31 $10
2018-09-30 $8
2018-06-30 $9
2018-03-31 $7
2017-12-31 $7
2017-09-30 $5
2017-06-30 $5
2017-03-31 $5
2016-12-31 $5
2016-09-30 $5
2016-06-30 $6
2016-03-31 $4
2015-12-31 $5
2015-09-30 $6
2015-06-30 $6
2015-03-31 $4
2014-12-31 $3
2014-09-30 $5
2014-06-30 $6
2014-03-31 $4
2013-12-31 $4
2013-09-30 $0
2013-06-30 $5
2013-03-31 $4
2012-12-31 $4
2012-09-30 $5
2012-06-30 $5
2012-03-31 $4
2011-12-31 $8
2011-09-30 $4
2011-06-30 $5
2011-03-31 $4
2010-12-31 $4
2010-09-30 $4
2010-06-30 $4
2010-03-31 $3
2009-12-31 $2
2009-09-30 $3
2009-06-30 $4
2009-03-31 $3
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.324B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00